Technologieangebote

In-vitro process for quick determination of the status of an infection with an influenza virus type

The novel test system can discriminate T cell immunity induced by an acute encounter of influenza viruses from lasting T cell immunity after earlier infections or preceding vaccinations and may help to guide antiviral therapy. The test system can be performed out of whole blood, following a multi-dimensional T cell immunomonitoring of cytokine profiles after specific antigen stimulation. The processing time is only 8 hours.

Weitere Informationen: PDF

Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Tel.: +49 (0)681/302-71302

Ansprechpartner
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Nicole Comtesse, Dr. Frank Döbrich

Kommentare (0)

Schreiben Sie einen Kommentar